UM

Urmilaben Maheshbhai Patel

Active Director Director DIN 00632511
DIN 00632511 First appointment Sep 2005 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Sep 2005
Shareholding value •••• Premium profile

About Urmilaben Maheshbhai Patel

Data last updated:

Urmilaben Maheshbhai Patel is a Director at Shree Ramkrishna Chem Tech Private Limited (since 2021) and Director at Bhavik Chem Private Limited (since 2016). The companies operate in Chemicals and Materials, Agriculture and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.81 Cr; the largest is Shree Ramkrishna Chem Tech Private Limited at ₹5.74 Cr (FY 2024). Earlier, Urmilaben Maheshbhai Patel was a Director at Pragna Speciality Private Limited (2021–2024) and Director at Pragna Pharma Private Limited (2012–2022) and 1 more.

DIN 00632511
Primary Designation Director
Industry Chemicals and Materials
First Appointment 25 Sep 2005
Oldest Company Age 14 yrs
Largest company Shree Ramkrishna Chem Tech Private Limited · ₹5.74 Cr (FY 2024)
Combined revenue ₹5.81 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Mar 20212021₹5.74 Cr (FY 2024)Active
Bhavik Chem Private Limited U24100GJ2012PTC068516
Director01 Aug 20162012₹7.1 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pragna Speciality Private Limited U24299GJ2021PTC121406
Director20 Mar 20212021₹10.84 Cr (FY 2024)Active
Pragna Pharma Private Limited U24110GJ2012PTC068475
Director04 Jan 20122012₹149 Cr (FY 2025)Active
Pragna Dyechem Private Limited U24110GJ2005PTC046797
Director25 Sep 20052005₹48.78 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bhavik Chem Private Limited
Shree Ramkrishna Chem Tech Private Limited
Pragna Speciality Private Limited
Pragna Pharma Private Limited
Premium access

Shareholding and investment profile for Urmilaben Maheshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmilaben Maheshbhai Patel

Urmilaben Maheshbhai Patel currently holds 2 directorships: Shree Ramkrishna Chem Tech Private Limited (Director, since 24 Mar 2021, revenue ₹5.74 Cr (FY 2024)); Bhavik Chem Private Limited (Director, since 01 Aug 2016, revenue ₹7.1 Lakh (FY 2025)).

Urmilaben Maheshbhai Patel was first appointed on 25 Sep 2005 as Director at Pragna Dyechem Private Limited. The most recent appointment on record is 24 Mar 2021 at Shree Ramkrishna Chem Tech Private Limited.

The 2 current companies of Urmilaben Maheshbhai Patel that report revenue have a combined latest revenue of ₹5.81 Cr: Shree Ramkrishna Chem Tech Private Limited ₹5.74 Cr (FY 2024); Bhavik Chem Private Limited ₹7.1 Lakh (FY 2025).

Urmilaben Maheshbhai Patel held 3 earlier board appointments: Pragna Speciality Private Limited (Director, 20 Mar 2021 to 14 Mar 2024); Pragna Pharma Private Limited (Director, 04 Jan 2012 to 02 Sep 2022); Pragna Dyechem Private Limited (Director, 25 Sep 2005 to 31 Aug 2022).

The current boards of Urmilaben Maheshbhai Patel's companies include Bhavik Maheshkumar Patel (Shree Ramkrishna Chem Tech Private Limited), Dharmendra Kantilal Patel (Shree Ramkrishna Chem Tech Private Limited), Dipakkumar Shankarlal Patel (Bhavik Chem Private Limited), Jigneshkumar Kalidas Patel (Bhavik Chem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available